Lv1
100 积分 2023-03-04 加入
P3‐029: EFFICACY AND SAFETY OF OXIRACETAM IN PATIENTS WITH VASCULAR COGNITIVE IMPAIRMENT (OVERCOME): DESIGN AND RATIONALE FOR A MULTICENTER, RANDOMIZED, DOUBLE‐BLINDED, PLACEBO‐CONTROLLED, PARALLEL‐DESIGN, PHASE IV CLINICAL TRIAL
24天前
已完结
Management of psychiatric and cognitive complications in Parkinson’s disease
25天前
已完结
Pharmacokinetic Properties of S-oxiracetam After Single and Multiple Intravenous Infusions in Healthy Volunteers
29天前
已完结
重视帕金森病冲动控制障碍临床识别与研究
1个月前
已完结
Deve-se realizar a colecistectomia profilática durante a gastroplastia redutora para tratamento da obesidade mórbida?
1个月前
已完结
帕金森病治疗指南
1个月前
已完结
German Society of Neurology guidelines for the diagnosis and treatment of cognitive impairment and affective disorders in people with Parkinson’s disease: new spotlights on diagnostic procedures and non-pharmacological interventions
2个月前
已完结
Safety, tolerability, and pharmacokinetics of oral (S)-oxiracetam in Chinese healthy volunteers: a randomized, double-blind, controlled phase I study
2个月前
已完结
皖公网安备34019202002308
